Skip to content

13G/A filed by Decheng Capital Global Life Sciences Fund IV, L.P.

Decheng Capital Global Life Sciences Fund IV, L.P. and 2 other reporting persons reported 2,724,868 UPB shares, 4.9% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-10-29 20:13:09 UTC.

Accession
0001834150-26-000006
Filer
CIK 1834150
Filed
2026-10-29
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Stake

Shares
2,724,868
Percent of class
4.9%
Event date
2026-09-30

How the shares relate across the reporting persons: every reporting person reports the same shares (a chain of control). The page shows the largest row.

Read for the filer group Decheng Capital Global Life Sciences Fund IV, L.P..

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
Decheng Capital Global Life Sciences Fund IV, L.P.PN02,724,86802,724,8682,724,8684.9%
Decheng Capital Management IV (Cayman), LLCOO02,724,86802,724,8682,724,8684.9%
Xiangmin CuiIN02,724,86802,724,8682,724,8684.9%